Verbruggen Bas, Bickley Lisa K, van Aerle Ronny, Bateman Kelly S, Stentiford Grant D, Santos Eduarda M, Tyler Charles R
Biosciences, College of Life & Environmental Sciences, Geoffrey Pope Building, University of Exeter, Exeter, Devon EX4, UK.
European Union Reference Laboratory for Crustacean Diseases, Centre for Environment, Fisheries and Aquaculture Science (Cefas), Weymouth Laboratory, Weymouth, Dorset DT4 8UB, UK.
Viruses. 2016 Jan 18;8(1):23. doi: 10.3390/v8010023.
Since its emergence in the 1990s, White Spot Disease (WSD) has had major economic and societal impact in the crustacean aquaculture sector. Over the years shrimp farming alone has experienced billion dollar losses through WSD. The disease is caused by the White Spot Syndrome Virus (WSSV), a large dsDNA virus and the only member of the Nimaviridae family. Susceptibility to WSSV in a wide range of crustacean hosts makes it a major risk factor in the translocation of live animals and in commodity products. Currently there are no effective treatments for this disease. Understanding the molecular basis of disease processes has contributed significantly to the treatment of many human and animal pathogens, and with a similar aim considerable efforts have been directed towards understanding host-pathogen molecular interactions for WSD. Work on the molecular mechanisms of pathogenesis in aquatic crustaceans has been restricted by a lack of sequenced and annotated genomes for host species. Nevertheless, some of the key host-pathogen interactions have been established: between viral envelope proteins and host cell receptors at initiation of infection, involvement of various immune system pathways in response to WSSV, and the roles of various host and virus miRNAs in mitigation or progression of disease. Despite these advances, many fundamental knowledge gaps remain; for example, the roles of the majority of WSSV proteins are still unknown. In this review we assess current knowledge of how WSSV infects and replicates in its host, and critique strategies for WSD treatment.
自20世纪90年代出现以来,白斑病(WSD)在甲壳类水产养殖行业造成了重大的经济和社会影响。多年来,仅对虾养殖就因白斑病遭受了数十亿美元的损失。这种疾病由白斑综合征病毒(WSSV)引起,WSSV是一种大型双链DNA病毒,也是尼马病毒科的唯一成员。多种甲壳类宿主对WSSV易感,这使其成为活体动物运输和商品中的主要风险因素。目前,这种疾病尚无有效的治疗方法。了解疾病过程的分子基础对许多人类和动物病原体的治疗有显著贡献,出于类似目的,人们也投入了大量精力来了解白斑病的宿主 - 病原体分子相互作用。由于缺乏宿主物种的测序和注释基因组,水生甲壳类动物发病机制的分子机制研究受到了限制。尽管如此,一些关键的宿主 - 病原体相互作用已经明确:感染开始时病毒包膜蛋白与宿主细胞受体之间的相互作用、各种免疫系统途径对WSSV的反应以及各种宿主和病毒微小RNA在疾病缓解或进展中的作用。尽管取得了这些进展,但仍存在许多基础知识空白;例如,大多数WSSV蛋白的作用仍然未知。在这篇综述中,我们评估了目前关于WSSV如何在其宿主中感染和复制的知识,并对白斑病的治疗策略进行了评论。